https://www.selleckchem.com/pr....oducts/tat-beclin-1-
Primary hepatic squamous cell carcinoma (SCC) is a rare, highly aggressive liver cancer that is associated with intrahepatic stone, liver cirrhosis, hepatic cyst, and Caroli's disease. At present, there are no settled therapy guidelines for primary hepatic SCC. Patients with successful surgical resection have a tumor-free survival of approximately 6 to 9 months.(1,2) Immune checkpoint inhibitors (ICIs) are a promising treatment for multiple tumor types, with significant efficacy and manageable toxicity.(3).Enantioresoluti
Mi piace
Commento
Condividi
